Liryc – the heart rhythm disease institute – has recently acquired a state-of-the-art scanner featuring dual photon counting technology. This advance opens up promising prospects for better identification of patients at risk of sudden cardiac death.
Compared to a conventional scanner, the detectors in a photon-counting scanner can make a big difference. The pixels of photon-counting detectors are much smaller, providing much better spatial resolution. Thanks to this new technology, patients are exposed to an even lower radiation dose and a smaller amount of contrast medium. For researchers, this means they can work with images that show extremely fine tissue structures, and are therefore more accurate (Source: Siemens Healthineers).
The deployment of this latest-generation scanner opens up promising prospects for our teams’ ability to more accurately identify patients at risk of sudden cardiac death. This photonic scanner will enable us to see what is currently invisible with a CT or MRI scan, but which we suspect to exist – tiny scars in the heart muscle.
Pr Pierre Jaïs, General director of Liryc
The acquisition of this dual-photon-counting scanner marks an important milestone in the mission of Liryc’s teams to tackle heart rhythm disorders and improve patients’ quality of life. It also demonstrates the Institute’s ongoing commitment to remaining at the cutting edge of technology to push back the frontiers of medical research and healthcare innovation.